A Study of V503 Given Concomitantly With Menactra™ and Adacel™ in 11 to 15 Year Olds (V503-005)

Clinical trial NCT00988884 · COMPLETED

Trial details

NCT number: NCT00988884
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Human Papillomavirus Infection

Start date: 2009-10-21
Primary completion: 2011-02-22
Enrollment: 1241

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.